Clinical Research Site

Brooklyn, New York 11235

4 studies enrolling now · 12 studies all time

What they study most

Agitation, Agitation in Patients With Dementia of the Alzheimer's Type, Agitation, Psychomotor, Agitation,Psychomotor, Alzheimer Disease, Cataplexy, Essential Hypertension, Excessive Daytime Sleepiness, Fibromyalgia, Major Depressive Disorder, Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms, Narcolepsy

Studies at this site

• Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol — Recruiting now
• Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design — Recruiting now
• A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms — Recruiting now
• Open-Label Safety Study of AXS-14 in Subjects With Fibromyalgia — Enrolling by invitation
• An Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects With Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension Study — Stopped early
• A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy — Completed
• Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using Solriamfetol — Completed
• A Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease Agitation — Completed
• A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation — Completed
• Assessing Clinical Outcomes in Alzheimer's Disease Agitation — Completed
• Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type — Completed
• An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension — Completed